Sign in with Google. Opens in new tab
bearish
Srf - Weakness in the Chemicals Business Hampers Performance
SRF posted weak performance in 2QFY25, with a material decline in operating profitability (EBIT down 22% YoY), due to the continuous weakness in the Chemicals business (EBIT dipped 29% YoY).
What is covered in the Full Insight:
- Introduction and Overview
- Financial Performance Analysis
- Segment-wise Breakdown
- Management Commentary
- Valuation and Future Outlook
SUMMARY
(Sign Up to Access)Full Insight
(Paid Plans Only, 26-minute read)
Related Insights
More »Loading
Trending Collections
More »Loading
Trending Insights
More »Top Unpaywalled Insights
More »- Curator's Cut: Building Materials Moves, Benchmarking Gold Miners & Semaglutide in India and Japan
- [IO Technicals 2025/25] Bearish Momentum Strengthens
- VEON (VEON US): Launches Third Phase of Share Buyback Program After Share Pullback
- Valuations, Visas & Venture Pullback: An Equity + M&A Overview of the Education Sector in Q1 2025
- Overview #27 – The Big Beautiful Tragi-Comedy Continues
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Srf - Weakness in the Chemicals Business Hampers Performance25 Oct 2024
x